Pharmacological treatment for depression during opioid agonist treatment for opioid dependence (Q24235458)

4

0 references

Emanuela Trogu

3

0 references

Pier Paolo Pani

1

0 references

author name string

Rosangela Vacca

Cochrane Database of Systematic Reviews

2

0 references

publication date

8 September 2010

0 references

published in

0 references

cites work

The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

A randomised, controlled trial of fluoxetine in methadone maintenance patients with depressive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Comorbid Major Depressive Disorder as a Prognostic Factor in Cocaine‐Abusing Buprenorphine‐Maintained Patients Treated with Desipramine and Contingency Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Desipramine treatment of cocaine dependence in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Psychopathology and attrition in the Baltimore ECA 15-year follow-up 1981-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Buprenorphine treatment of refractory depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Depression among needle exchange program and methadone maintenance clients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Psychiatric and substance use comorbidity among treatment-seeking opioid abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Dopamine reuptake by norepinephrine neurons: exception or rule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Polydrug dependence and psychiatric comorbidity among heroin injectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Patterns of major depression and drug-related problems amongst heroin users across 36 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Methadone maintenance at different dosages for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Opioid dependence: rationale for and efficacy of existing and new treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Suicide as an outcome for mental disorders. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

A 33-year follow-up of narcotics addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Serotonin syndrome triggered by a single dose of suboxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Antidepressants for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

The Fifth Edition of the Addiction Severity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

The mesolimbic dopamine reward circuit in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Attrition factors in clinical trials of comorbid bipolar and substance-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Treatment of depression in patients with opiate dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

A brief self-report depression measure assessing mood state and social impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: recent preclinical and clinical insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Profile of Mood States: The Factors and Their Physiological Correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

REPLICATION OF FACTORS OF PSYCHOPATHOLOGY IN INTERVIEW, WARD BEHAVIOR AND SELF-REPORT RATINGS OF HOSPITALIZED DEPRESSIVES

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Long-term changes in current psychiatric diagnoses of treated opiate addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Community reinforcement approach for combined opioid and cocaine dependence. Patterns of engagement in alternate activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Increasing opiate abstinence through voucher-based reinforcement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Medication adherence strategies for drug abusers with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

A Structured Interview Guide for the Hamilton Depression Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Factors influencing the self-rating depression scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

7 January 2021

Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

7 January 2021

Imipramine as Treatment for Depression in Addicts

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

7 January 2021

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

7 January 2021

Screening depressed patients in family practice. A rapid technic

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

7 January 2021

Assessing depressive symptoms in five psychiatric populations: a validation study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

7 January 2021

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

7 January 2021

Early treatment time course of depressive symptoms in opiate addicts

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

7 January 2021

Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008373.PUB2

7 January 2021